Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)
Clinical trial NCT03775486 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03775486
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-21
- Primary completion
- 2021-01-11
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.